A new study estimating the cost of introducing and delivering malaria vaccine (RTS,S/AS01E) in areas of seasonal malaria transmission found the mass campaign strategy to be the most expensive approach, followed by mixed-delivery strategies and routine EPI delivery. The study, published in BMJ Global Health, prospectively estimated the cost in Mali and Burkina Faso.
The findings include that, at an assumed vaccine price of US$5 per dose, the economic cost per dose administered ranges between $7.73 and $8.68 (mass campaign), $7.04 and $7.38 (routine EPI), and $7.26 and $7.93 (mixed delivery). Excluding commodities, the cost ranges between $1.17 and $2.12 (mass campaign), $0.48 and $0.82 (routine EPI), and $0.70 and $1.37 (mixed delivery). The financial non-commodity cost per dose administered ranges between $0.99 and $1.99 (mass campaign), $0.39 and $0.76 (routine EPI), and $0.58 and $1.28 (mixed delivery).
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.